Inventor · disambiguated record
Catherine Gerard
Also filed as: GERARD CATHERINE · GERARD CATHERINE M G · GERARD CATHERINE MARIE G · GERARD CATHERINE MARIE GHISLAI
3 granted patents·19 pending applications·286 citations·filing 2000–2017
74Inventor score
Files withSMITHKLINE BEECHAM BIOLOG4BRUCK CLAUDINE E M2FRIEDE MARTIN2BRICHARD VINCENT1BRUCK CLAUDINE ELVIRE MARIE1
Top patents by PatentIndex Score
22 records- 0197US6544518B1VaccinesSMITHKLINE BEECHAM BIOLOG·Filed 2000·Granted Apr 8, 2003·272 cites·15 claims
- 0285US7399472B2VaccinesSMITHKLINE BEECHAM BIOLOG·Filed 2003·Granted Jul 15, 2008·14 cites·17 claims
- 0371US2008311156A1VaccinesFRIEDE MARTIN·Filed 2008·Application pending·0 cites
- 0470US2008095788A1VaccinesFRIEDE MARTIN·Filed 2007·Application pending·0 cites
- 0556US2010008980A1Use of MAGE A3-Protein D Fusion Antigen in Immunotherapy Combined with Surgery, Chemotherapy or Radiotherapy for the Treatment of CancerBRICHARD VINCENT·Filed 2008·Application pending·0 cites
- 0656US2009081127A1Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor responseMOSER MURIEL·Filed 2008·Application pending·0 cites
- 0752US2007212328A1Immunogenic CompositionsBRUCK CLAUDINE E M·Filed 2004·Application pending·0 cites
- 0852US2004202648A1VaccinesFiled 2004·Application pending·0 cites
- 0952US2005031638A1VaccineSMITHKLINE BEECHAM BIOLOG·Filed 2004·Application pending·0 cites
- 1052US2008249013A1VaccinesGLAXOSMITHKLINE BIOLOG SA·Filed 2008·Application pending·0 cites
- 1152US2007212329A1Vaccine Compositions Comprising An Interleukin 18 And Saponin Adjuvant SystemBRUCK CLAUDINE E M·Filed 2004·Application pending·0 cites
- 1247US2003118562A1Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor responseFiled 2002·Application pending·0 cites
- 1347US2006140965A1Immunogenic compositions comprising a xenogenic prostate protein p501sCASSART JEAN-POL·Filed 2003·Application pending·0 cites
- 1447US2003031656A1Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor responseFiled 2002·Application pending·0 cites
- 1547US2010028414A1Combination of tyrosine kinase inhibitor and her-2/neu for cancer therapyBRUCK CLAUDINE ELVIRE MARIE·Filed 2005·Application pending·0 cites
- 1646US2002141973A1Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor responseFiled 2001·Application pending·0 cites
- 1745US2005019340A1VaccinesFiled 2001·Application pending·0 cites
- 1843US2001012632A1Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor responseFiled 2001·Application pending·0 cites
- 1942US2015147350A1Method Of Treating Cancer With MEGEA3 Immunotherapeutic With BRAF Inhibitor And/Or MEK InhibitorGLAXOSMITHKLINE LLC·Filed 2012·Application pending·0 cites
- 2041US11040095B2Human rhinovirus vaccineGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Granted Jun 22, 2021·0 cites·15 claims
- 2140US2002182221A1Recombinant papillomavirus vaccine and method for production and treatmentSMITHKLINE BEECHAM BIOLOG·Filed 2001·Application pending·0 cites
- 2238US2004047869A1Adjuvant composition comprising an immunostimulatory oligonucleotide and a tocolFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →